Amber Gibson
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Interests
Subspecializes in pediatric leukemia and lymphomas, including acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma and mature B-cell lymphomas.
Education & Training
Degree-Granting Education
| 2016 | University of North Texas Health Science Center, Forth Worth, Texas, US, Doctor of Osteopathic Medicine |
| 2012 | Texas A&M University, Corpus Christi, Texas, US, Bachelor of Arts in Psychology |
| 2012 | Texas A&M University, Corpus Christi, Texas, US, Bachelor of Science in Biomedical Science |
Postgraduate Training
| 2019-2022 | Clinical Fellowship, Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2016-2019 | Clinical Residency, Pediatric Residency, The University of Oklahoma- OU Children’s Hospital, Oklahoma City, Oklahoma |
Licenses & Certifications
| 2023 | American Board of Pediatrics- Pediatric Hematology/Oncology |
| 2019 | American Board of Pediatrics |
| 2019 | Texas Medical License |
Experience & Service
Administrative Appointments/Responsibilities
Fellowship Director at Memorial Hermann Children's Hospital, Memorial Hermann–Texas Medical Center, Houston, Texas, 2026 - Present
Site Director for Subspecialty Pediatric Fellows, Pediatrics - Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Medical Director of Pediatric Subspecialty Services, Pediatrics - Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Intramural Institutional Committee Activities
Peer Messenger, Center for Professionalism Support & Success, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, Pediatric Oncology Fellow Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Co-Lead, Pediatric Clinical Practice Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, The Samuel J. Hassenbusch III MD, PhD PRS award selection committee, The University of Texas MD Anderson Cancer Center, 2025 - 2025
Member, Pediatric Hospice and Palliative Medicine (PHPM) Fellowship, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, CCH Executive Leadership Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, The Samuel J. Hassenbusch III MD, PhD PRS award selection committee, The University of Texas MD Anderson Cancer Center, 2024 - 2024
Member, PRS Faculty Compensation & Benefit Advisory Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Search Committee Interviewer- Dr. Diana Osorio, Pediatric Neuro Onc Candidate Search Committee, The University of Texas MD Anderson Cancer Center, 2023
Content expert committee member, Scientific Review Committee # 1 (SRC 1) MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Pediatric Morbidity and Mortality Conference Review Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Trainee Representative-Active role in content creation for GME podcast curriculum, Graduate Medical Education Curriculum Subcommittee, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Member, Pediatric Clinical Practice Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2025
Member, Pediatric Education Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Extramural Institutional Committee Activities
Member, Texas Children's Practice Standards Committee, Texas Children's Hospital, 2026 - Present
Panel Member, Panel for Pediatric Acute Myeloid Leukemia, The National Comprehensive Cancer Network, 2025 - Present
Member, NCCN Pediatric Aggressive Mature B cell Lymphomas Guildeline, National Comprehensive Cancer Network, 2023 - Present
Editorial Activities
Guest Editor, Children: Special Issue: Pediatric Leukemia: Immunotherapy and Precision Medicine, 2026 - Present
Honors & Awards
| 2023 | MD Anderson's Celebration of Faculty Excellence- Community Outreach, The University of Texas MD Anderson Cancer Center |
| 2023 | Faculty Excellence in Service, The University of Texas MD Anderson Cancer Center |
| 2022 | Scholarly Activity Fellow of the Year award, The University of Texas MD Anderson Cancer Center |
| 2022 | Hematology Fellow of the Year award, The University of Texas MD Anderson Cancer Center |
| 2021 | Pediatric Leukemia and Lymphoma Fellow of the Year award, The University of Texas MD Anderson Cancer Center |
| 2021 | Chief Fellow, The University of Texas MD Anderson Cancer Center |
| 2020 | Pediatric Neuro-oncology Fellow of the Year award, The University of Texas MD Anderson Cancer Center |
| 2020 | Fellow of the year ‘Awesome Job Award’ 2020, The University of Texas MD Anderson Cancer Center |
| 2019 | Owen M. Rennert Research Award, OU Children’s Hospital |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2021. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board exam Preparation and Improve Perception of Learner Board Preparation. Conference. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board exam Preparation and Improve Perception of Learner Board Preparation, US.
- 2021. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board exam Preparation and Improve Perception of Learner Board Preparation. Conference. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board exam Preparation and Improve Perception of Learner Board Preparation, US.
- 2018. VITA for patients with relapsed central nervous system malignancies: Combination therapy with vincristine, irinotecan, temozolomide, and antibiotic. Conference. VITA for patients with relapsed central nervous system malignancies: Combination therapy with vincristine, irinotecan, temozolomide, and antibiotic. Denver, CO, US.
- Actinomyces Epidural Abscess: A Virtually Unheard of Process in the Virtual Age. Conference. Actinomyces Epidural Abscess: A Virtually Unheard of Process in the Virtual Age. New Orleans, LA, US.
National Presentations
- 2026. Targeted Therapy for Pediatric AML. Panelist. NCCN Acute Myeloid Leukemia Guideline Development. Plymouth Meeting, Pennsylvania, US.
- 2025. Tumor Stage Mycosis Fungoides in a Pediatric Patient. Invited. United States Cutaneous Lymphoma Consortium: Pediatric Presentations. Mechanicsburg, Pennsylvania, US.
- 2021. Venetoclax for Acute Myeloid Leukemia in pediatric patients: A Texas Medical Center Collaboration. Conference. Venetoclax for Acute Myeloid Leukemia in pediatric patients: A Texas Medical Center Collaboration, US.
- 2021. Pembrolizumab in combination with antigen-specific cytotoxic T lymphocytes enhances killing of acute myeloid leukemia. Conference. Pembrolizumab in combination with antigen-specific cytotoxic T lymphocytes enhances killing of acute myeloid leukemia, US.
- 2021. Once a day compared to twice a day enoxaparin in children with venous thromboembolism: a single center experience. Conference. Once a day compared to twice a day enoxaparin in children with venous thromboembolism: a single center experience, US.
- 2021. Risk factors for 3rd or greater relapses in AYA patients with classical Hodgkin Lymphoma: The MD Anderson Cancer Center Experience. Conference. Risk factors for 3rd or greater relapses in AYA patients with classical Hodgkin Lymphoma: The MD Anderson Cancer Center Experience, US.
- 2021. Venetoclax for Acute Lymphoblastic Leukemia in Pediatric Patients: The MD Anderson Cancer Center Experience. Conference. Venetoclax for Acute Lymphoblastic Leukemia in Pediatric Patients: The MD Anderson Cancer Center Experience, US.
- 2021. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: The MD Anderson Experience. Conference. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: The MD Anderson Experience, US.
- 2021. Impact of Body Mass Index (BMI) on overall relapse of Classical Hodgkin Lymphoma. Conference. Impact of Body Mass Index (BMI) on overall relapse of Classical Hodgkin Lymphoma, US.
- 2021. Nodular Lymphocyte Predominant Hodgkin Lymphoma in AYA, MD Anderson Cancer Center’s 20-year experience. Conference. Nodular Lymphocyte Predominant Hodgkin Lymphoma in AYA, MD Anderson Cancer Center’s 20-year experience, US.
- 2021. AYA with Mixed Cellularity Classical Hodgkin Lymphoma: The MD Anderson Cancer Center, 20-year Experience. Conference. AYA with Mixed Cellularity Classical Hodgkin Lymphoma: The MD Anderson Cancer Center, 20-year Experience, US.
- 2020. Not the medication, It’s the tubing system: A case of anaphylaxis to medicine delivery tubing system. Conference. Not the medication, It’s the tubing system: A case of anaphylaxis to medicine delivery tubing system, US.
- 2020. Incidence of proteinuria in NF2 patients receiving Avastin. Conference. Incidence of proteinuria in NF2 patients receiving Avastin, US.
International Presentations
- 2025. Oral Hypomethylating Agents in Pediatric AML. Invited. New Agents in Leukemia. Utrecht, NL.
- 2020. Clinical characterization and outcome; our experience of chordomas in pediatric and young adults. Conference. Clinical characterization and outcome; our experience of chordomas in pediatric and young adults, JP.
Selected Publications
Peer-Reviewed Articles
- Gibson A. A New Paradigm for Pediatric AML: Improving the Pipeline for Treatments Targeting Cytogenetic and Molecular Alterations. Leukemia, 2026. e-Pub 2026.
- Gibson A. The State of the Field and Future Needs Impact of a Pediatric Onco-Hospitalist Model on Inpatient Oncology Care Delivery, 2026.
- Gibson A. Hematologica. Blood. e-Pub 2026.
- Al Qanber Batool, Gibson A. Obinutuzumab, polatuzumab vedotin, and glofitamab for relapsed or refractory pediatric/AYA burkitt leukemia and lymphoma. Blood Advances, 2026. e-Pub 2026.
- Catueno, S, Frost, M, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Malpica Castillo, LE, Garcia, MB. Uncommon Presentation and Therapeutic Strategies in Pediatric Relapsed/Refractory ALK-Positive ALCL. Journal of Pediatric Hematology/Oncology 48(3):125-127, 2026. e-Pub 2026. PMID: 41818168.
- Okeleji O, McCall D, Cuglievan B, Gibson A, Petropoulos D, Tewari P, Connors J, Sheikh I. Immune-Related Toxicity Profile After Hematopoeitc Stem Cell Transplantation in Patients with B-ALL Given Combination Immunotherapy with Rituximab, Inotuzumab and Blinatumomab. British Journal of Haematology, 2026. e-Pub 2026. PMID: 41582414.
- Garcia MB, Wang B, Sheikh I, El Hajjar G, McCall D, Nunez C, Gibson A, Lorenzi PL, Issa GC, Cuglievan B, Abbas HA. High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition. Mol Cell Proteomics 25(3):101522, 2026. e-Pub 2026. PMID: 41621809.
- Raj R, Catueno S, Gibson A, McCall D, Garcia MB, Nunez C, Roth M, Sasaki K, Tewari P, Issa GC, Farhat A, Connors J, Sheikh I, Nishida Y, Yi JS, Stevens AM, Bataller A, Bhalla K, Petropoulos D, Daver N, Kadia T, Cuglievan B, DiNardo CD. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood 146(21):2608-2611, 2025. e-Pub 2025. PMID: 40971491.
- Catueno S, Ramakrishnan R, Elitzur S, Garcia MB, McCall D, Nunez C, Roth M, Ferrajoli A, Cuglievan B, Gibson A. Lymphoid Malignancies in Ataxia-Telangiectasia: Experience with Novel Targeted Therapies. Pediatr Blood Cancer 72(9):e31885, 2025. e-Pub 2025. PMID: 40605148.
- Berkman AM, Andersen CR, Puthenpura V, Short NJ, Merriman K, Swaminathan M, Cuglievan B, McCall D, DiNardo C, Nunez C, Jain N, Kadia T, Issa G, Gibson A, Garcia MB, Livingston J, Parsons S, T Hildebrandt MA, Roth ME. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectr, 2025. e-Pub 2025. PMID: 40579211.
- He, J, Munir, F, Ayerbe, C, Dickson, S, Catueno, S, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garcia, MB, Rodriguez, NI, Cortes, JA. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients. Journal of Pediatric Hematology/Oncology 47(5):235-241, 2025. e-Pub 2025. PMID: 40306291.
- Elgehiny A, Hsu A, McCall D, Gibson A, Cuglievan B, Nunez C, Garcia MB, Castellanos L, Funck A, Razvi S. Severe Hypertriglyceridemia Secondary to Long-Acting Asparaginase in Pediatric Patients With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol 47(6):e215-e221, 2025. e-Pub 2025. PMID: 40560745.
- Corrigan KL, Berkman AM, Gunther J, Andersen CR, Wu S, Gibson A, Cuglievan B, Garcia MB, Manzar G, Fang P, De B, Ahmed S, Nunez C, Hildebrandt MAT, McCall DC, Parsons SK, Roth ME. Trends in Radiation Use from 2004-2020 Among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev 34(9):1483-1491, 2025. e-Pub 2025. PMID: 40488452.
- Okeleji O, McCall D, Gibson A, Garcia MB, Nunez C, Roth M, Connors J, Petropoulos D, Tewari P, Cuglievan B, Sheikh IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Adv 9(8):1988-1990, 2025. e-Pub 2025. PMID: 39993239.
- McCall, DC, Alqahtani, S, Budak, M, Sheikh, IN, Fan, AE, Ramakrishnan, R, Nunez, CA, Roth, M, Garcia, M, Gibson, A, Daver, N, Garces, S, Short, NJ, Issa, GC, Ravandi-Kashani, F, DiNardo, C, Montalban Bravo, G, Garcia-Manero, G, Cuglievan, B, Kadia, TM. Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients. Cancers 16(22), 2024. e-Pub 2024. PMID: 39594839.
- Gibson, A, Dickson, S, McCall, DC, Garcia, M, Connors, JS, He, J, Roth, M, Nunez, CA, Cuglievan, B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatric Blood and Cancer 71(11), 2024. e-Pub 2024. PMID: 39152634.
- Elitzur, S, Shiloh, R, Loeffen, J, Pastorczak, A, Takagi, M, Bomken, S, Baruchel, A, Lehrnbecher, T, Tasian, SK, Abla, O, Arad-Cohen, N, Astigarraga, I, Ben-Harosh, M, Bodmer, N, Brozou, T, Ceppi, F, Chugaeva, L, Dalla Pozza, L, Ducassou, S, Escherich, G, Farah, R, Gibson, A, Hasle, H, Hoveyan, J, Jacoby, E, Jazbec, J, Junk, SV, Kolenova, A, Lazic, J, Lo Nigro, L, Mahlaoui, N, Miller, L, Papadakis, V, Pecheux, L, Pillon, M, Sarouk, I, Starý, J, Stiakaki, E, Strullu, M, Tran, TH, Ussowicz, M, Verdu-Amoros, J, Wakulinska, A, Zawitkowska, J, Stoppa-Lyonnet, D, Taylor, AM, Shiloh, Y, Izraeli, S, Minard, V, Schmiegelow, K, Nirel, R, Attarbaschi, A, Borkhardt, A. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies. Blood 144(11):1193-1205, 2024. e-Pub 2024. PMID: 38917355.
- McCall, DC, Abuasab, T, Rodriguez-Sevilla, JJ, Mohamed, SF, Patnaik, A, Devireddy, K, Arani, N, Sheikh, IN, Jamshidi, R, Gibson, A, Roth, M, Nunez, CA, Garcia, M, Chien, KS, Loghavi, S, Pierce, S, Sasaki, K, Issa, GC, Cuglievan, B, Kantarjian, H, Garcia-Manero, G. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms. Leukemia Research 144, 2024. e-Pub 2024. PMID: 39178611.
- Gibson, A, Nunez, CA, Robusto, L, Kammerer, B, Garcia, M, Roth, M, Sheth, RK, Tewari, P, Hittle, A, Toepfer, L, Torres, R, Short, NJ, Jabbour, EJ, Jain, N, Cuglievan, B, McCall, DC. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109(9):3042-3047, 2024. e-Pub 2024. PMID: 38779719.
- Short NJ, Jabbour E, Jamison T, Paul S, Cuglievan B, McCall D, Gibson A, Jain N, Haddad FG, Nasr LF, Marx KR, Rausch C, Savoy JM, Garris R, Ravandi F, Kantarjian H. Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 24(4):e168-e173, 2024. e-Pub 2024. PMID: 38212207.
- He J, Garcia MB, Connors JS, Nunez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. J Pediatr Hematol Oncol 45(8):e1001-e1004, 2023. e-Pub 2023. PMID: 37661300.
- Truong DD, Lamhamedi-Cherradi SE, Porter RW, Krishnan S, Swaminathan J, Gibson A, Lazar AJ, Livingston JA, Gopalakrishnan V, Gordon N, Daw NC, Navin NE, Gorlick R, Ludwig JA. Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC Cancer 23(1):488, 2023. e-Pub 2023. PMID: 37254069.
- Trabal A, Gibson A, He J, McCall D, Roth M, Nunez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, Daver N, Kadia T, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garces S, Marcogliese A, Paek H, Dreyer Z, Brackett J, Redell M, Yi J, Garcia-Manero G, Konopleva M, Stevens A, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046645.
- Gibson A, Ragoonanan D, Tewari P, Petropoulos D, Rodriguez N, DiNardo C, Mahadeo KM, Khazal S. Non-myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita. Pediatr Transplant 26(2):e14157, 2022. e-Pub 2022. PMID: 34626046.
- Gibson A, Trabal A, McCall D, Khazal S, Toepfer L, Bell DH, Roth M, Mahadeo KM, Nunez C, Short NJ, DiNardo C, Konopleva M, Issa GC, Ravandi F, Jain N, Borthakur G, Kantarjian HM, Jabbour E, Cuglievan B. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancers (Basel) 14(1), 2021. e-Pub 2021. PMID: 35008312.
- Gibson A, Baig MU, Mohiuddin S, Zaky W. Neither iatrogenic nor hereditary cause: A rare case of anaphylaxis to low sorb tubing used for infusions. Pediatr Blood Cancer 68(4):e28800, 2021. e-Pub 2021. PMID: 33164273.
- Gibson A, Ray A. Rare Case of Hybrid Oncocytoma and Chromophobe Renal Cell Carcinoma in a Pediatric Patient. Pediatr Blood Cancer 63(6):1127, 2016. e-Pub 2016. PMID: 26718018.
Review Articles
- McCall D, Catueno S, Ramakrishnan R, Tewari P, Sheikh I, Gibson A, Nunez CA, Garcia MB, Cuglievan B. Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia. Acta Haematol 149(1):84-100, 2026. e-Pub 2026. PMID: 40324358.
- Cuglievan, B, Kantarjian, HM, Rubnitz, JE, Cooper, T, Zwaan, CM, Pollard, J, DiNardo, C, Kadia, TM, Guest, E, Short, NJ, McCall, DC, Daver, N, Nunez, CA, Haddad, FG, Garcia, MB, Bhalla, K, Maiti, A, Catueno, S, Fiskus, WC, Carter, BZ, Gibson, A, Roth, M, Khazal, SJ, Tewari, P, Abbas, HA, Bourgeois, W, Andreeff, M, Shukla, N, Truong, D, Connors, JS, Ludwig, JA, Stutterheim, J, Salzer, E, Juul-Dam, KL, Sasaki, K, Mahadeo, KM, Tasian, SK, Borthakur, G, Dickson, S, Jain, N, Jabbour, EJ, Meshinchi, S, Garcia-Manero, G, Ravandi, F, Stein, EM, Kolb, EA, Issa, GC. Menin inhibitors in pediatric acute leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
- He, J, Munir, F, Catueno, S, Connors, JS, Gibson, A, Robusto, L, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garces, S, Cuglievan, B, Garcia, MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473221.
- Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
- Gibson A, Montanez N, Addy K, Hashmi SS, Brown D, Rodriguez N, Menon N, Srivaths L. Once-daily Compared With Twice-daily Enoxaparin Maintenance Therapy Appears Safe and Efficacious in Pediatric Venous Thromboembolism. J Pediatr Hematol Oncol 45(5):e655-e659, 2023. e-Pub 2023. PMID: 36449733.
- Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
- Gibson A, Hernandez C, Tejada FNH, Kawedia J, Rytting M, Cuglievan B. Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives. Paediatr Drugs 23(5):457-463, 2021. e-Pub 2021. PMID: 34351604.
Abstracts
- Gibson A, Ramakrishnan R, Srivaths L, Fraser S, Rodriguez N, Andersen C. Cerebral Sinovenous Thrombosis with asparaginase use in pediatric leukemia - MD Anderson experience. International Society on Thrombosis and Haemostasis, 2025. e-Pub 2025.
- Frost M, Catueno S, Raj R, Gibson A, Garcia MB, Roth M, Nunez C, Cuglievan B, McCall D. Pleocytosis in Cerebrospinal Fluid During Blinatumomab Therapy in Pediatric B-ALL: A Retrospective Review. The American Society of Pediatric Hemotology/Oncology, 2025. e-Pub 2025.
- Trabal A, Gibson A, McCall D, Mahadeo KM, Toepfer L, Roth ME, Buzbee M, Kadia TM, Garces S, Konopleva M, DiNardo CD, Daver N, Short NJ, Issa GC, Ravandi F, Nunez C, Khazal SJ, Paek H, Brackett J, Garcia-Manero G, …, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration. American Society of Hematology, 2024. e-Pub 2024.
- David McCall MD, Branko Cuglievan MD, Amber Gibson DO, Miriam B Garcia DO, Michael E Roth MD, Cesar Nunez MD. A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine (ZiVA) in Pediatric Relapsed and Refractory Acute Leukemias. American Society of Hematology, 2024. e-Pub 2024.
- Reeja Raj DO, Samanta Catueno MD, Amber Gibson DO, David McCall MD, Miriam B Garcia DO, Cesar Nunez MD, Michael E Roth MD, Koji Sasaki MD, Priti Tewari MD, Branko Cuglievan MD, DiNardo MDMSc CD. FLAG IDA Venetoclax in Newly Diagnosed Pediatric and AYA Patients with AML. American Society of Hematology, 2024. e-Pub 2024.
- David McCall MD, Amber Gibson DO, Miriam B Garcia DO, Cesar Nunez MD, Michael E Roth MD, Branko Cuglievan MD. Phase II Study of Pedi-Crib: Mini-Hyper-CVD with Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric Patients with B-Cell Lineage Acute Lymphocytic Leukemia. American Society of Hematology, 2024. e-Pub 2024.
- Sarah Elitzur MD, Ruth Shiloh PhD, MDPhD JL, Jan Loeffen MDPhD, Masatoshi Takagi MD PhD, Simon Bomken MD PhD, Andre Baruchel MD, Stephane Ducassou, Nizar Mahlaoui, Marion Strullu, Thomas Lehrnbecher MD, Kjeld Schmiegelow, Oussama Abla MD, Liliia Anderzhanova MD, Nira Arad-Cohen MD, Itziar Astigarraga, Miriam Ben-Harosh MD, Francesco Ceppi MD, Nicole Bodmer MD, Triantafyllia Brozou MD, Luciano Dalla-Pozza MD, Gabriele Escherich MD, Roula Farah MD, Amber Gibson DO, Hasle H, Julieta Hoveyan MD, Elad Jacoby MD, Janez Jazbec, Alexandra Kolenova, Jelena Lazic, Luca Lo Nigro MD, Lane Miller MD, Vassilios Papadakis, Lucie Pecheux MD, MD PhD MP, Ifat Sarouk MD, Jan Stary, Eftichia Stiakaki MD, Sarah K Tasian MD, Thai Hoa Tran MD, Marek Ussowicz, Jose Jaime Verdu-Amoros MD, Anna Wakulinska MD, Joanna Zawitkowska, Dominique Stoppa-Lyonnet, Malcolm Taylor, Yosef Shiloh, Shai Izraeli MD, Ronit Nirel, Veronique Minard-Colin, Attarbaschi A, Arndt Borkhardt MD. ATM Germline Pathogenic Variants Affect Treatment Outcomes in Children with Acute Lymphoblastic Leukemia/Lymphoma and Ataxia Telangiectasia. American Society of Hematology, 2023. e-Pub 2023.
- Shaikha Alqahtani MD, Ramya Ramakrishnan MD, Cesar Nunez MD, David McCall MD, Miriam B Garcia DO, Branko Cuglievan MD, Amber Gibson DO. Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia. American Society of Hematology, 2023. e-Pub 2023.
- Ghayas C Issa MD, Branko Cuglievan MD, Courtney D. DiNardo, Nicholas J Short MD, David McCall MD, Amber Gibson DO, Cesar Nunez MD, Miriam B Garcia DO, Michael Roth MD, Aram Bidikian MD, Allison Pike RN, Sheila Tan RN, Brianna Kammerer BSN, Musa Yilmaz MD, Tapan M Kadia MD, Naveen Pemmaraju MD, Maro Ohanian DO, Naval Daver MD, Elias Jabbour MD, Gautam Borthakur MD, Hagop M Kantarjian MD. Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE). American Society of Hematology, 2023. e-Pub 2023.
- Trabal A, Gibson A, McCall D, Mahadeo KM, Toepfer L, Roth ME, Buzbee M, Kadia TM, Garces S, Konopleva M, DiNardo CD, Daver N, Short NJ, Issa GC, Ravandi F, Nunez C, Khazal SJ, Paek H, Brackett J, Garcia-Manero G, …, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration, 2021. e-Pub 2021.
- Gibson A, Zhang M, Sukhumalchandra P, Philips AV, Qiao N, Perakis AA, Kerros C, John LS, Clise-Dwyer K, Lu S, Ma Q, Molldrem JJ, Alatrash G. Pembrolizumab in Combination with Antigen-Specific Cytotoxic T Lymphocytes Enhances Killing of Acute Myeloid Leukemia. American Society of Hematology, 2021. e-Pub 2021.
- Ramakrisnan R, Okeleji O, Gibson A, Nunez C, Roth M, Garcia M, Cuglievan B, McCall D. Successful Treatment of Relapsed Pediatric B-ALL Harboring TCF3-HLF Fusion Transcript with Pedi-cRIB Regimen. COG Fall Meeting, 2024.
- Raja R, Ramakrishnan R, McCall D, Gibson A, Cuglievan B, Nunez C, Brown B, Bray M, Garcia M. Hemophagocytic Lymphohistiocytosis in an Infant with Confounding Primary and Secondary Diagnostic Factors. COG Fall Meeting 2024.
- Catueno S, Nash A, Wanes P, McCall D, Garcia M, Roth M, Nunez C, Cuglievan B, Gibson A. Use of Immunotherapy and Targeted Therapy in EPOR-IGH BALL. COG Fall Meeting, 2024.
- Raj R, Gibson A, McCall D, Cuglievan B, Nunez C, Roth M, Garcia M. Neurotoxicity in Pediatric ALL: Insights into Methotrexate-Associated Risk Factors, Timing, and Management Strategies. The American Society of Pediatric Hemotology/Oncology.
- Elgehiny A, Elsamny E, McCall D, Cuglievan B, Harrison, Gibson Amber. HEMATURIA IN A PEDIATRIC PATIENT WITH LEUKEMIA: WHEN BACK PAIN BECOMES A DOUBLE-EDGED CLUE. The American Society of Pediatric Hemotology/Oncology.
- Frost M, Raj R, Cantueno, Garcia M, Roth M, Nunez C, Cuglievan B, McCall, Gibson A. PERIPHERAL EOSINOPHILIA IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH BLINATUMOMAB. The American Society of Pediatric Hemotology/Oncology.
- Cohen E, Okeleji O, Tewari P, McCall D, Razvi S, Herzog C, Garcia M, Nunez C, Cuglivan B, Harrison D, Gibson A. SYNCHRONOUS MEDIASTINAL GERM CELL TUMOR WITH SARCOMATOUS TRANSFORMATION AND ACUTE MYELOID LEUKEMIA. The American Society of Pediatric Hemotology/Oncology.
- Chauv L, Gibson A, Sukhumalchandra P, Hsu A, Kurian N, Karavias A, Navarro M, Thomas A, St John L, Osilesi O, Lanete R, Peng S, Kerros C, Qiao N, Philips A, Zhang M, Shi C, Yan J, Zha D, Sergeeva A, Hong H, Molldrem J, Al-Atrash G. Cross-presented serine proteases as immunotherapy targets for lung cancer and osteosarcoma. Catalyst CPRIT CURE.
- McCall D, Hittle A, Cuglievan B, Jabbour E, Short N, Jain N, Catueno S, Garcia M, Nunez C, Roth M, Toepfer L, Torres R, Gibson A. Next-generation sequencing as a powerful tool for measurab. American Society of Hematology.
- Cuglievan B, Okeleji O, Catueno S, McCall D, Garcia M, Gibson A, Nunez C, Roth M, Farhat A, Hajjar GE, Garces S, Balch A, Stevens A, Yi J, Sasaki K, Sheikh I, Connors J, Petropoulos D, Tewari P, Issa G. Post-transplant maintenance with revumenib in children with HOX-driven AML. American Society of Hematology.
- Cvrtak A, Nebral K, Boztug H, Abla O, Antoniou E, Buldini B, Czogala M, Haas VD, Gibson A, Gizhlaryan M, Goemans B, Haltrich I, Inaba H, Jacob N, Juul-Dam K, Kelaidi C, Klco J, Mühlegger N, Patel T, Pigazzi M, Scheidegger N, Zaliova M, Abrahamsson J, Cooper T, Cuglievan B, Moerloose BD, Gibson B, Hasle H, Kaspers G, Locatelli F, Petit A, Polychronopoulou S, Reinhardt D, Rubio P, Stary J, Tasian S, Tomizawa D, Dworzak M. Clinical, cytogenetic and molecular characteriszation of Mecom- rearranged pediatric de novo Acute Myeloid Leukemia (AML): A retrospective cohort study of the international-berlin-frankfurtMünster (I-BFM) AML-study group. American Society of Hematology.
- Sheikh I, Raj R, Okeleji O, Catueno S, Fan A, McCall D, Gibson A, Garcia M, Connors J, Roth M, Nunez C, Petropoulos D, Cuglievan B, Tewari P. Positive outcomes associated with stem cell transplantation in pediatric/AYA patients who receive FLAG-IDA-venetoclax for high-risk AML. American Society of Hematology.
- Gibson A. Menin Inhibition Enables Curative-Intent Transplantation in a High-Risk Cohort of NUP98-Rearranged AML. Md Anderson Cancer Center.
- Nunez C, Gibson A, Cuglievan B, Ravandi F, Doherty E, Redell M, McCall D, Garcia M, Roth M, Robusto L, Sheth R, Rabin K, Short N. Successful treatment with response-adjusted Venetoclax dosing in combination with Azacytidine and Gilteritinib in FLT3-ITD positive refractory AML. Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023.
Book Chapters
- Gibson A, Catueno S. Pediatric Hematology-Oncology Rapid Review. In: Pediatric Hematology-Oncology Rapid Review. 1st. Walters Kluwer, 376, 2026.
Letters to the Editor
- Cohen, E, Okeleji, O, McCall, DC, Garcia, MB, Nunez, CA, Cuglievan, B, Herzog, CE, Razvi, S, Tewari, P, Douglas, H, Gibson, A. Synchronous Mediastinal Germ Cell Tumor with Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatric Blood and Cancer 72, 2025.
- Nash, A, Dinh, CN, Kawedia, J, McCall, DC, Weinman, S, Garcia, M, Roth, M, Nunez, CA, Cuglievan, B, Gibson, A. Calasparagase Pegol Induced Hemolytic Anemia. Pediatric Blood and Cancer 72, 2025.
- Nash, A, Weirda, WG, Albritton, KH, Cuglievan, B, Garcia, MB, McCall, DC, Nunez, CA, Gibson, A. Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy. Pediatric Blood and Cancer 71, 2024.
- Alqahtani, S, Ramakrishnan, R, Shuyu, E, Wang, S, Nunez, CA, McCall, DC, Garcia, MB, Roth, M, Cuglievan, B, Gibson, A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatric Blood and Cancer 71, 2024.
- Okeleji, O, Gibson, A, Nunez, CA, Garcia, MB, Roth, M, Cuglievan, B, McCall, DC. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma. Pediatric Blood and Cancer 71, 2024.
- Sarkar, S, Rav, ES, Stitzlein, LM, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Ragoonanan, D, Connors, JS, Herzog, CE, Cuglievan, B, Garcia, MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatric Blood and Cancer 71, 2024.
- Sheikh, IN, Alqahtani, S, Yin, CC, McCall, DC, Cuglievan, B, Ragoonanan, D, Connors, JS, Gibson, A, Nunez, CA, Roth, M, Ohanian, M, Borthakur, G, Garcia, MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatric Blood and Cancer 71, 2024.
Patient Reviews
CV information above last modified August 23, 2026